Warsaw University Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2005
NCT02092558
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Children's Hospital, Dziekanów Leśny, Poland | Dept of Gastroenterology and Hepatology, Roentgena, Warsaw, Poland | Institute of Psychiatry and Neurology, Warsaw | Institute of Psychiatry and Neurology, Warsaw, Poland | Roentgena, Warsaw, Poland | University of Warsaw

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Esophagitis, Peptic (Phase 3)

Gastroesophageal Reflux (Phase 3)

Heartburn (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6